Clin2
NCT06160232Possibly a fitRecruiting

Psilocybin therapy for severe alcohol use disorder

Severe Alcohol Use Disorder

Treatments studied

Part of Mental health clinical trials.

This trial tests whether psilocybin, a psychedelic substance, combined with talk therapy can help people with severe alcohol use disorder stop or reduce drinking. Participants will first complete a 4-week inpatient detox program before receiving psilocybin in a supervised setting.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
62 people
Ages
21 years to 64 years
Study type
Interventional

Who can take part

  • You are between 21 and 64 years old
  • You have been diagnosed with severe alcohol use disorder and want to stop or cut down
  • You are willing to stay alcohol-free during a 4-week detox program at the hospital
  • You are not currently taking any medications for alcohol use disorder and can pause other interacting medications
  • You do not have certain heart conditions, liver disease, or other unstable health problems
  • You do not have a history of psychotic disorders, bipolar disorder, or major depression with psychosis

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06378229Recruiting· Phase 2
Psilocybin for hospitalized treatment-resistant depression

This trial tests whether a single dose of psilocybin can help hospitalized patients with tough-to-treat depression. It focuses on people who haven't improved with standard antidepressants and need a new option.

Ghent, Oost-Vlaanderen
NCT07296094Not yet recruiting· Phase 2
Psilocybin therapy for severe alcohol use disorder

This trial tests whether a single dose of psilocybin (the active ingredient in 'magic mushrooms') combined with therapy can help people with severe alcohol use disorder reduce or stop drinking. It's for people who've recently completed detox and are ready to commit to a structured program in Boston.

Boston, Massachusetts
NCT06444243Not yet recruiting· Phase 2
Psilocybin therapy for alcohol use disorder

This trial tests whether a psilocybin (magic mushroom) therapy session can help people with alcohol use disorder reduce their drinking. You'll have one or two guided sessions with a therapist, plus support before and after, to see if it helps you change your drinking habits.

NCT06349083Recruiting· Phase 2
Psilocybin-assisted treatment for alcohol use disorder

This study tests whether psilocybin, a psychedelic drug, combined with therapy can help people reduce or stop drinking. It aims to understand how psilocybin affects the brain and behavior in people with alcohol use disorder.

New York, New York
NCT07638553Recruiting· Phase 3
Psilocybin to prevent alcohol relapse with depression

This study tests whether psilocybin (a psychedelic compound) can help people with severe alcohol use disorder stay sober longer, especially if they also have depression. Participants receive guided psilocybin sessions alongside counseling to reduce the risk of returning to heavy drinking.

Bayonne
NCT07405606Not yet recruiting· Phase 2
Psilocybin therapy for depression and alcohol use disorder

This study tests whether a drug called psilocybin, given along with therapy, can help people who have both major depression and alcohol use disorder. You may be a good fit if you have tried other treatments or don't want to start new medications.

Toronto, Ontario

Hear when a new Severe Alcohol Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.